Diosmetin Inhibits NETs Formation in Neutrophils Through Regulating Nrf2 Signaling
Thoracic Cancer · 2025
DOI: 10.1111/1759-7714.70040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Lijuan Guo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Extracellular Traps, Neutrophils, Flavonoids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, the Natural Science Foundation of Sichuan Provine.
Abstract (Originalsprache)
Background
Neutrophil extracellular traps (NETs) are important pieces of equipment for neutrophils. Excess NETs play promoting roles in cancer‐associated thrombosis (CAT). Therefore, directing NETs formation is a promising therapeutic strategy in thrombosis and related diseases. Diosmetin, an antioxidant flavonoid derived from dietary sources, might be involved in NETs formation and CAT.
Methods
Firstly, the tests of cell‐free DNA and Immunofluorescence were applied to evaluate the NETs levels of neutrophils. Luminol‐based chemiluminescence and the DCFH‐DA probe were used to detect the levels of reactive oxygen species (ROS) in neutrophils. Then, network pharmacological analysis and molecular docking were used to predict potential target molecules of diosmetin. The RT‐qPCR was performed to measure the levels of Nrf2 and HO‐1. A series of functional assays of neutrophils were used to examine the effect of diosmetin on other neutrophil functions. Finally, an animal model of deep vein thrombosis was constructed to assess the effect of diosmetin on thrombosis.
Results
Diosmetin reduced NETs and ROS levels in neutrophils. Then, molecular mechanisms analysis suggested that Nrf2 might be the primary target of diosmetin. Diosmetin treatment increased the levels of Nrf2 and HO‐1 in NETs‐generating neutrophils. An inhibitor of Nrf2 diminished the negative effect of diosmetin on NETs generation. Lastly, the murine thrombosis model results indicated that diosmetin treatment reduced thrombosis via NETs formation.
Conclusion
Diosmetin exerts as anti‐NETs effect through Nrf2 signaling in neutrophils, showing the therapeutic potential in thromboembolism and related pathological processes, such as CAT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan, China.
- State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan,…
ORCID-Profile: Jingyu Li
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- the Natural Science Foundation of Sichuan Provine
- Sichuan Association for Science and Technology
- Foundation of State Key Laboratory of Component-based Chinese Medicine
Zitieren
APA
Guo, L., Luo, H., Lei, Y., Gu, L., Wang, Y., Wang, S., Lian, Z., Li, Y., Xiang, Y., Du, G., Shao, R., Tian, X., Zhang, H., Shen, L., Chen, J., Wang, Y., Huang, N., Niu, X., & Li, J. (2025). Diosmetin Inhibits NETs Formation in Neutrophils Through Regulating Nrf2 Signaling. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70040
Vancouver
Guo L, Luo H, Lei Y, Gu L, Wang Y, Wang S, et al. Diosmetin Inhibits NETs Formation in Neutrophils Through Regulating Nrf2 Signaling. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70040
BibTeX
@article{Guo2025,
author = {Guo, Lijuan and Luo, Hongyang and Lei, Yuxin and Gu, Leiyan and Wang, Yaohui and Wang, Siyuan and Lian, Zihan and Li, Yuhao and Xiang, Yanlan and Du, Guanhua and Shao, Rui and Tian, Xiaoxuan and Zhang, Han and Shen, Linjie and Chen, Junli and Wang, Yi and Huang, Ning and Niu, Xiaoyu and Li, Jingyu},
title = {Diosmetin Inhibits NETs Formation in Neutrophils Through Regulating Nrf2 Signaling},
journal = {Thoracic Cancer},
year = {2025},
doi = {10.1111/1759-7714.70040}
}
EUVIMED